昊帆生物
(301393)
| 流通市值：21.85亿 | | | 总市值：56.04亿 |
| 流通股本：4210.48万 | | | 总股本：1.08亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 270,298,471.51 | 135,213,242.04 | 451,874,668.1 | 328,158,737.06 |
| 营业收入 | 270,298,471.51 | 135,213,242.04 | 451,874,668.1 | 328,158,737.06 |
| 二、营业总成本 | 200,149,046.57 | 102,006,985.59 | 320,336,611.16 | 228,599,500.59 |
| 营业成本 | 161,306,618.37 | 82,708,972.55 | 269,852,206.07 | 191,553,471 |
| 税金及附加 | 2,656,055.4 | 1,416,117.8 | 4,178,065.22 | 2,553,778.66 |
| 销售费用 | 8,051,955.73 | 3,832,441.99 | 13,596,937.8 | 9,686,865.68 |
| 管理费用 | 14,923,747.55 | 7,148,311.3 | 29,529,803.99 | 23,460,639.15 |
| 研发费用 | 19,260,122.3 | 9,861,294.55 | 35,991,848.34 | 26,225,248.09 |
| 财务费用 | -6,049,452.78 | -2,960,152.6 | -32,812,250.26 | -24,880,501.99 |
| 其中:利息费用 | 49,404.41 | 26,566.61 | 91,293.5 | 34,786.56 |
| 其中:利息收入 | 7,544,180.7 | 3,408,207.74 | 29,727,232.8 | 28,050,784.16 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 5,444,086.14 | 1,317,903.57 | 5,636,108.35 | 8,537,868.52 |
| 加:投资收益 | 9,950,840.4 | 6,025,752.73 | 10,950,889.64 | 1,172,551.34 |
| 资产处置收益 | -93,989.15 | -93,989.15 | -32,052.89 | -58,976.15 |
| 资产减值损失(新) | -610,495.36 | -386,538.6 | -2,661,553.64 | -1,369,210.16 |
| 信用减值损失(新) | -387,503.22 | -1,141,392.53 | -2,509,435.62 | -3,248,675.25 |
| 其他收益 | 2,653,970.82 | 1,438,915.64 | 12,969,342.67 | 6,400,906.92 |
| 四、营业利润 | 87,106,334.57 | 40,366,908.11 | 155,891,355.45 | 110,993,701.69 |
| 加:营业外收入 | 44,752.12 | 4,876.22 | 120,434.03 | 118,889.22 |
| 减:营业外支出 | 31,795.45 | 933.23 | 1,375,650.43 | 565,246.74 |
| 五、利润总额 | 87,119,291.24 | 40,370,851.1 | 154,636,139.05 | 110,547,344.17 |
| 减:所得税费用 | 11,234,489.25 | 5,571,873.66 | 20,583,221.99 | 14,212,148.52 |
| 六、净利润 | 75,884,801.99 | 34,798,977.44 | 134,052,917.06 | 96,335,195.65 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 75,884,801.99 | 34,798,977.44 | 134,052,917.06 | 96,335,195.65 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 75,884,801.99 | 34,798,977.44 | 134,052,917.06 | 96,335,195.65 |
| 扣除非经常损益后的净利润 | 62,000,384.85 | 28,015,509.2 | 115,649,120.14 | 83,603,997.72 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.71 | 0.33 | 1.25 | 0.9 |
| (二)稀释每股收益 | 0.7 | 0.32 | 1.24 | 0.89 |
| 八、其他综合收益 | 142,913.01 | 25,030.11 | - | - |
| 归属于母公司股东的其他综合收益 | 142,913.01 | 25,030.11 | - | - |
| 九、综合收益总额 | 76,027,715 | 34,824,007.55 | 134,052,917.06 | 96,335,195.65 |
| 归属于母公司股东的综合收益总额 | 76,027,715 | 34,824,007.55 | 134,052,917.06 | 96,335,195.65 |
| 公告日期 | 2025-08-29 | 2025-04-28 | 2025-04-11 | 2024-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |